Downregulation of ITIH3 contributes to cisplatin‑based chemotherapy resistance in ovarian carcinoma via the Bcl‑2 mediated anti‑apoptosis signaling pathway

Author:

Liu Yingzhao1,Shi Lijun2,Yuan Cunzhong3,Feng Yan4,Li Mengdi5,Liu Hongmei5,Chen Xi5,Yao Desheng1,Wang Qi5

Affiliation:

1. Department of Gynecologic Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

2. Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

3. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China

4. Research Department, Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

5. Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference40 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. The rediscovery of platinum-based cancer therapy;Rottenberg;Nat Rev Cancer,2021

3. Treatment of epithelial ovarian cancer;Kuroki;BMJ,2020

4. Ovarian cancer;Matulonis;Nat Rev Dis Primers,2016

5. Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer;Shi;Zhonghua Fu Chan Ke Za Zhi,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3